AG
SURF

Artal Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Artal Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$478K – 151
2021
Q4 		$478K Hold
100,000
– – 0.01% 148
2021
Q3 		$757K Hold
100,000
– – 0.02% 142
2021
Q2 		$746K Hold
100,000
– – 0.02% 142
2021
Q1 		$780K Hold
100,000
– – 0.01% 143
2020
Q4 		$924K Buy
+100,000
New +$869K 0.02% 128

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group's SURF Position: Q1 2022 in Review

Artal Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 100,000 shares — an estimated $478K sold.

Artal Group first reported a position in SURF in Q4 2020 and held it in 5 quarters. The position peaked at $924K in Q4 2020. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • Artal Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Artal Group sold 100,000 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $478K.
  • Artal Group first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Artal Group's Surface Oncology, Inc. Common Stock position peaked at $924K in Q4 2020.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Artal Group's 13F filing for Q1 2022, filed 12 May 2022.